172 related articles for article (PubMed ID: 4048939)
1. X-ray structure of the major adduct of the anticancer drug cisplatin with DNA: cis-[Pt(NH3)2(d(pGpG))].
Sherman SE; Gibson D; Wang AH; Lippard SJ
Science; 1985 Oct; 230(4724):412-7. PubMed ID: 4048939
[TBL] [Abstract][Full Text] [Related]
2. Molecular structure of the complex formed between the anticancer drug cisplatin and d(pGpG): C222(1) crystal form.
Coll M; Sherman SE; Gibson D; Lippard SJ; Wang AH
J Biomol Struct Dyn; 1990 Oct; 8(2):315-30. PubMed ID: 2268406
[TBL] [Abstract][Full Text] [Related]
3. Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation.
Fichtinger-Schepman AM; van der Veer JL; den Hartog JH; Lohman PH; Reedijk J
Biochemistry; 1985 Jan; 24(3):707-13. PubMed ID: 4039603
[TBL] [Abstract][Full Text] [Related]
4. Replication inhibition and translesion synthesis on templates containing site-specifically placed cis-diamminedichloroplatinum(II) DNA adducts.
Comess KM; Burstyn JN; Essigmann JM; Lippard SJ
Biochemistry; 1992 Apr; 31(16):3975-90. PubMed ID: 1314653
[TBL] [Abstract][Full Text] [Related]
5. The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques.
Plooy AC; Fichtinger-Schepman AM; Schutte HH; van Dijk M; Lohman PH
Carcinogenesis; 1985 Apr; 6(4):561-6. PubMed ID: 4039227
[TBL] [Abstract][Full Text] [Related]
6. Guanine-06 methylation reduces the reactivity of d(GpG) towards platinum complexes.
Struik AF; Zuiderwijk CT; van Boom JH; Elding LI; Reedijk J
J Inorg Biochem; 1991 Dec; 44(4):249-60. PubMed ID: 1765785
[TBL] [Abstract][Full Text] [Related]
7. A novel technique to assay adducts of DNA induced by anticancer agent cis-diamminedichloroplatinum(II).
Sharma M; Jain R; Isac TV
Bioconjug Chem; 1991; 2(6):403-6. PubMed ID: 1805936
[TBL] [Abstract][Full Text] [Related]
8. Chemical and biological studies of the major DNA adduct of cis-diamminedichloroplatinum(II), cis-[Pt(NH3)2(d(GpG]], built into a specific site in a viral genome.
Naser LJ; Pinto AL; Lippard SJ; Essigmann JM
Biochemistry; 1988 Jun; 27(12):4357-67. PubMed ID: 3166983
[TBL] [Abstract][Full Text] [Related]
9. Formation of a DNA monofunctional cis-platinum adduct cross-linking the intercalating drug N-methyl-2,7-diazapyrenium.
Malinge JM; Sip M; Blacker AJ; Lehn JM; Leng M
Nucleic Acids Res; 1990 Jul; 18(13):3887-91. PubMed ID: 2374713
[TBL] [Abstract][Full Text] [Related]
10. cis-Platinum induced distortions in DNA. Conformational analysis of d(GpCpG) and cis-pt(NH3)2[d(GpCpG)], studied by 500-MHz NMR.
den Hartog JH; Altona C; van Boom JH; Marcelis AT; van der Marel GA; Rinkel LJ; Wille-Hazeleger G; Reedijk J
Eur J Biochem; 1983 Aug; 134(3):485-95. PubMed ID: 6684039
[TBL] [Abstract][Full Text] [Related]
11. Novel binding interactions of the DNA fragment d(pGpG) cross-linked by the antitumor active compound tetrakis(mu-carboxylato)dirhodium(II,II).
Chifotides HT; Koshlap KM; Pérez LM; Dunbar KR
J Am Chem Soc; 2003 Sep; 125(35):10714-24. PubMed ID: 12940757
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic studies of a novel class of trisubstituted platinum(II) antitumor agents.
Hollis LS; Sundquist WI; Burstyn JN; Heiger-Bernays WJ; Bellon SF; Ahmed KJ; Amundsen AR; Stern EW; Lippard SJ
Cancer Res; 1991 Apr; 51(7):1866-75. PubMed ID: 2004370
[TBL] [Abstract][Full Text] [Related]
13. Conformational analysis of the adduct cis-[Pt(NH3)2 d(GpG)]+ in aqueous solution. A high field (500-300 MHz) nuclear magnetic resonance investigation.
den Hartog JH; Altona C; Chottard JC; Girault JP; Lallemand JY; de Leeuw FA; Marcelis AT; Reedijk J
Nucleic Acids Res; 1982 Aug; 10(15):4715-30. PubMed ID: 6890203
[TBL] [Abstract][Full Text] [Related]
14. Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities.
Trimmer EE; Zamble DB; Lippard SJ; Essigmann JM
Biochemistry; 1998 Jan; 37(1):352-62. PubMed ID: 9425057
[TBL] [Abstract][Full Text] [Related]
15. Immunochemical quantitation of adducts induced in DNA by cis-diamminedichloroplatinum (II) and analysis of adduct-related DNA-unwinding.
Fichtinger-Schepman AM; Baan RA; Luiten-Schuite A; van Dijk M; Lohman PH
Chem Biol Interact; 1985 Nov; 55(3):275-88. PubMed ID: 4075437
[TBL] [Abstract][Full Text] [Related]
16. Interaction of cis-[Pt(NH3)2(H2O)2](NO3)2 with ribose deoxyribose diguanosine phosphates.
Girault JP; Chottard G; Lallemand JY; Chottard JC
Biochemistry; 1982 Mar; 21(6):1352-6. PubMed ID: 6280759
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against cisplatin-modified DNA and cisplatin-modified (di)nucleotides.
Terheggen PM; Floot BG; Lempers EL; van Tellingen O; Begg AC; den Engelse L
Cancer Chemother Pharmacol; 1991; 28(3):185-91. PubMed ID: 1855275
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the DNA damage recognized by an antiserum elicited against cis-diamminedichloroplatinum (II)-modified DNA.
Reed E; Gupta-Burt S; Litterst CL; Poirier MC
Carcinogenesis; 1990 Dec; 11(12):2117-21. PubMed ID: 1979937
[TBL] [Abstract][Full Text] [Related]
19. Escherichia coli DNA polymerase I: inherent exonuclease activities differentiate between monofunctional and bifunctional adducts of DNA and cis- or trans-diamminedichloroplatinum(II). An exonuclease investigation of the kinetics of the adduct formation.
Bernges F; Dörner G; Holler E
Eur J Biochem; 1990 Aug; 191(3):743-53. PubMed ID: 2167853
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of trans-[Pt(NH3)2Cl2] adducts of d(CCTCGAGTCTCC).d(GGAGACTCGAGG).
Lepre CA; Chassot L; Costello CE; Lippard SJ
Biochemistry; 1990 Jan; 29(3):811-23. PubMed ID: 2159792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
